Cargando…

Host-Based Treatments for Severe COVID-19

COVID-19 has been a global health problem since 2020. There are different spectrums of manifestation of this disease, ranging from asymptomatic to extremely severe forms requiring admission to intensive care units and life-support therapies, mainly due to severe pneumonia. The progressive understand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mondini, Lucrezia, Salton, Francesco, Trotta, Liliana, Bozzi, Chiara, Pozzan, Riccardo, Barbieri, Mariangela, Tavano, Stefano, Lerda, Selene, Hughes, Michael, Confalonieri, Marco, Confalonieri, Paola, Ruaro, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136924/ https://www.ncbi.nlm.nih.gov/pubmed/37185727 http://dx.doi.org/10.3390/cimb45040203

Ejemplares similares

Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
por: Salton, Francesco, et al.
Publicado: (2023)

Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy
por: Mondini, Lucrezia, et al.
Publicado: (2023)

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
por: Ruaro, Barbara, et al.
Publicado: (2023)

Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
por: Ruaro, Barbara, et al.
Publicado: (2022)

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation
por: Cifaldi, Rossella, et al.
Publicado: (2023)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings
por: Salton, Francesco, et al.
Publicado: (2022)

Biomarkers in Systemic Sclerosis: An Overview
por: Di Maggio, Giuseppe, et al.
Publicado: (2023)

Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction
por: D’Oria, Mario, et al.
Publicado: (2022)

Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19
por: Salton, Francesco, et al.
Publicado: (2023)

An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease Definition: Is It Time to Incorporate the Concept of Failure of Lung Regeneration?
por: Confalonieri, Marco, et al.
Publicado: (2022)

High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Chronic Thromboembolic Pulmonary Hypertension: An Update
por: Ruaro, Barbara, et al.
Publicado: (2022)

Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
por: Pelosi, Paolo, et al.
Publicado: (2022)

Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
por: Confalonieri, Paola, et al.
Publicado: (2022)

Editorial: Obstructive sleep apnea syndrome (OSAS). What's new?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
por: Ruaro, Barbara, et al.
Publicado: (2022)

The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung
por: Ruaro, Barbara, et al.
Publicado: (2021)

Editorial: Evolution in respiratory pharmacology
por: Ruaro, Barbara, et al.
Publicado: (2023)

What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases?
por: Ruaro, Barbara, et al.
Publicado: (2020)

Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?
por: Ruaro, Barbara, et al.
Publicado: (2021)

The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

The Treatment of Lung Involvement in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated
por: Ruaro, Barbara, et al.
Publicado: (2021)

The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma
por: Antonaglia, Caterina, et al.
Publicado: (2022)

Limited role for bronchoalveolar lavage to exclude COVID-19 after negative upper respiratory tract swabs: a multicentre study
por: Geri, Pietro, et al.
Publicado: (2020)

Caution When Comparing the Impact of Corticosteroids in COVID-19
por: Confalonieri, Marco, et al.
Publicado: (2021)

Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
por: Baratella, Elisa, et al.
Publicado: (2021)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Low Arousal Threshold Estimation Predicts Failure of Mandibular Advancement Devices in Obstructive Sleep Apnea Syndrome
por: Antonaglia, Caterina, et al.
Publicado: (2022)

Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
por: Salton, Francesco, et al.
Publicado: (2023)

Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support
por: Torregiani, Chiara, et al.
Publicado: (2022)

Acute respiratory distress syndrome
por: Confalonieri, Marco, et al.
Publicado: (2017)

Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy
por: Baratella, Elisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ujnq9cel37q82ian8d0lens56b